NCT01547130

Brief Summary

A quality colonoscopy examination remains as the gold standard for colorectal cancer screening, but effective large bowel cleansing prior to colonoscopy is still not achieved in all cases that undergo the procedure. Currently, the most widely used cleansing methods employ balanced electrolyte-polyethylene glycol (PEG) solutions. However, a very large volume of PEG solution is required for it to be effective, and many patients refuse to drink a sufficient amount due to non-palatability. In this study, the investigators compare a novel colon preparation method--bolus lukewarm saline with yoga exercise--with a PEG based solution (HalfLytely) for large bowel cleansing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
133

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started May 2008

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 7, 2012

Completed
3 years until next milestone

Results Posted

Study results publicly available

March 4, 2015

Completed
Last Updated

March 4, 2015

Status Verified

February 1, 2015

Enrollment Period

2.6 years

First QC Date

February 26, 2012

Results QC Date

January 17, 2015

Last Update Submit

February 17, 2015

Conditions

Keywords

ColonoscopyYogaComplementary and alternative medicineBowel cleansingLarge bowel preparationCancer screeningColorectal cancer

Outcome Measures

Primary Outcomes (1)

  • Efficacy of Large Bowel Cleansing as Assessed by the Physician Performing the Colonoscopy

    The primary endpoint was the "success" rate of the preparations. Preparation efficacy was evaluated by a single, blinded endoscopist (V.A.), who performed all of the colonoscopies. The evaluation involved the rating of six anatomical segments of the colon (rectum, sigmoid, descending colon, transverse colon, ascending colon and cecum) on the 5 point Arya Bowel Prep Scale (ABPS). Aggregating the segmental scores resulted in overall scores. Grade A was defined as a total overall score of 19-24, grade B as a score of 13-18, grade C as a score of 7-12, and grade D as a score of 0-6. Grade A or B preparation was considered "successes", while grade C or D was considered "failures." To assess the reliability of ABPS, we trained 4 gastroenterologists and 3 fellows.

    Within 48 hours of bowel preparation

Secondary Outcomes (4)

  • Palatability of Bowel Prep

    Upto 24 weeks

  • Subjective Grading by Patients on Willingness to Repeat the Large Bowel Preparation.

    Upto 24 weeks

  • Patient-reported Adverse Events.

    Upto 24 weeks

  • Total Preparation Time

    Upto 24 weeks

Study Arms (2)

BLS and Yoga exercise

ACTIVE COMPARATOR

Patients will take a bolus intake of 8 oz. (240mL) to 16 oz. (480mL) of lukewarm saline water and perform yoga poses.

Drug: Normal (0.9%) saline

PEG (HalfLytely)

ACTIVE COMPARATOR

Patients followed the preparation method according to the manufacturer's standard instructions.

Drug: HalfLytely

Interventions

A total of 2L solution at lukewarm temperature (37.2-38.8 degrees Centigrade)consumed as bolus intake (8-16 oz in one to two minutes) alternating with yoga exercises.

BLS and Yoga exercise

A total of 2L solution prepared as per manufacturers instructions and sipped until bowel movements are clear.

PEG (HalfLytely)

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient scheduled to undergo elective complete colonoscopy as an outpatient.
  • Aged 18 or older.
  • The patient gives written informed consent and can understand the information given.
  • The patient can participate in the study only once.

You may not qualify if:

  • Sodium chloride sensitivity.
  • Limitation to exercise.
  • Earlier resection of the large bowel or rectum.
  • Known active colitis.
  • Ileus or gastrointestinal obstruction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vikalp Inc.

Middle Village, New York, 11379, United States

Location

Related Publications (1)

  • Arya V, Gupta KA, Valluri A, Arya SV, Lesser ML. Rapid colonoscopy preparation using bolus lukewarm saline combined with sequential posture changes: a randomized controlled trial. Dig Dis Sci. 2013 Aug;58(8):2156-66. doi: 10.1007/s10620-013-2598-9. Epub 2013 Mar 2.

MeSH Terms

Conditions

Colonic NeoplasmsColorectal Neoplasms

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Limitations and Caveats

Shudh Colon Cleanse (SCC) is suitable to only 30% of patients who are undergoing colonoscopy. A multi-center study is warranted to confirm these results.

Results Point of Contact

Title
Dr Vijaypal Arya
Organization
Wyckoff Heights Medical Center

Study Officials

  • Vijaypal Arya, MD

    Wyckoff Heights Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDIV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director, Endoscopy

Study Record Dates

First Submitted

February 26, 2012

First Posted

March 7, 2012

Study Start

May 1, 2008

Primary Completion

December 1, 2010

Study Completion

January 1, 2011

Last Updated

March 4, 2015

Results First Posted

March 4, 2015

Record last verified: 2015-02

Locations